Phibro Animal Health
PAHC
$28.00
Share price
0.21%
Change (1 day)
63.36%
Change (1 year)
Revenue for Phibro Animal Health (PAHC)
Revenue in 2025 (TTM): $1.19 Billion USD
According to Phibro Animal Health
's latest financial reports the company's current revenue (TTM 
) is $1.19 Billion USD. In 2024 the company made a revenue of $1.10 Billion USD an increase over the revenue in the year 2023 that were of $0.98 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Phibro Animal Health from 2013 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $1.19 B | 7.65% |
| 2024 | $1.10 B | 12.63% |
| 2023 | $0.98 B | 1.02% |
| 2022 | $0.97 B | 10.54% |
| 2021 | $0.87 B | 10.2% |
| 2020 | $0.79 B | -1.89% |
| 2019 | $0.81 B | -3.07% |
| 2018 | $0.83 B | 7.03% |
| 2017 | $0.78 B | 4.22% |
| 2016 | $0.75 B | 0.12% |
| 2015 | $0.75 B | 2.49% |
| 2014 | $0.73 B | 10.76% |
| 2013 | $0.66 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Heska Corporation
HSKA | $0.25 B | -78.59% | 🇺🇸 USA |
 Archer Daniels Midland (ADM)
ADM | $83.85 B | 6,942.85% | 🇺🇸 USA |
 Zoetis ZTS | $9.28 B | 679.89% | 🇺🇸 USA |
 Eli Lilly LLY | $49.00 B | 4,015.56% | 🇺🇸 USA |
 Merck MRK | $63.92 B | 5,268.52% | 🇺🇸 USA |
 Kindred Biosciences
KIN | $7.92 M | -99.33% | 🇺🇸 USA |